BIIB
Price
$217.15
Change
+$1.72 (+0.80%)
Updated
Sep 11 closing price
Capitalization
32.08B
47 days until earnings call
Intraday BUY SELL Signals
SCLX
Price
$5.01
Change
-$0.04 (-0.79%)
Updated
Sep 11 closing price
Capitalization
35.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

BIIB vs SCLX

BIIB vs SCLX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BIIB vs. SCLX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and SCLX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($32.1B) has a higher market cap than SCLX($35.2M). BIIB YTD gains are higher at: 23.388 vs. SCLX (6.170). BIIB has higher annual earnings (EBITDA): 2.14B vs. SCLX (-438.37M). BIIB has more cash in the bank: 1.29B vs. SCLX (581K). SCLX has less debt than BIIB: SCLX (97.8M) vs BIIB (8.36B). BIIB has higher revenues than SCLX: BIIB (10B) vs SCLX (31.6M).
BIIBSCLXBIIB / SCLX
Capitalization32.1B35.2M91,193%
EBITDA2.14B-438.37M-488%
Gain YTD23.3886.170379%
P/E Ratio38.57N/A-
Revenue10B31.6M31,646%
Total Cash1.29B581K221,170%
Total Debt8.36B97.8M8,543%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
23
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBSCLX
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (BIIB: $217.15 vs. SCLX: $5.01)
Brand notoriety: BIIB: Notable vs. SCLX: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 97% vs. SCLX: 45%
Market capitalization -- BIIB: $32.08B vs. SCLX: $35.24M
BIIB [@Pharmaceuticals: Major] is valued at $32.08B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $35.24M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $72.83K to $994.49B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $193.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 2 FA rating(s) are green while SCLX’s FA Score has 0 green FA rating(s).

  • BIIB’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, BIIB is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 3 TA indicator(s) are bullish while SCLX’s TA Score has 3 bullish TA indicator(s).

  • BIIB’s TA Score: 3 bullish, 5 bearish.
  • SCLX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BIIB and SCLX are a bad buy in the short-term.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а -1.67% price change this week, while SCLX (@Pharmaceuticals: Major) price change was -7.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.36%. For the same industry, the average monthly price growth was -3.99%, and the average quarterly price growth was +5.78%.

Reported Earning Dates

BIIB is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.36% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
BIIB
Daily Signal:
Gain/Loss:
SCLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD239.792.71
+1.14%
Steel Dynamics
SPFI44.760.12
+0.27%
South Plains Financial
SLGN38.630.06
+0.16%
Silgan Holdings
APRE0.78-0.01
-1.19%
Aprea Therapeutics
CURI2.66-0.05
-1.85%
CuriosityStream

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+0.80%
AMGN - BIIB
49%
Loosely correlated
-1.34%
AZN - BIIB
49%
Loosely correlated
+0.33%
PFE - BIIB
48%
Loosely correlated
+0.25%
MRK - BIIB
47%
Loosely correlated
-0.54%
ABBV - BIIB
41%
Loosely correlated
+0.83%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-0.79%
BIIB - SCLX
20%
Poorly correlated
+0.80%
AMRN - SCLX
20%
Poorly correlated
-1.71%
MIRA - SCLX
9%
Poorly correlated
-1.95%
MDCX - SCLX
6%
Poorly correlated
+0.74%
GILD - SCLX
5%
Poorly correlated
-0.75%
More